Potency of Fusion-Inhibitory Lipopeptides against SARS-CoV-2 Variants of Concern

Schmitz, K. S., Geers, D., de Vries, R. D., Bovier, T. F., Mykytyn, A. Z., Geurts van Kessel, C. H., Haagmans, B. L., Porotto, M., de Swart, R. L., & Moscona, A. (2022). Potency of Fusion-Inhibitory Lipopeptides against SARS-CoV-2 Variants of Concern. MBio, 13(3). https://doi.org/10.1128/mbio.01249-22
Authors:
Katharina S Schmitz
Daryl Geers
Rory D de Vries
T Francesca Bovier
Anna Z Mykytyn
Corine H Geurts van Kessel
Bart L Haagmans
Matteo Porotto
Rik L de Swart
Anne Moscona
Affiliated Authors:
T Francesca Bovier
Matteo Porotto
Anne Moscona
Subjects:
COVID-19 (MeSH)
SARS-CoV-2 (MeSH)
Author Keywords:
sars-cov-2
spike protein
fusion inhibitor
postvaccine sera
viral evolution
Publication Type:
Article
Unique ID:
10.1128/mbio.01249-22
PMID:
Journal:
Publication Date:
Data Source:
PubMed

Record Created: